NCT03988894

Brief Summary

The aim of this proposed study is to translate the Dietary Approach to Stop Hypertension with Sodium (Na) Reduction for Chinese Canadian (DASHNa-CC), a classroom-based antihypertensive dietary educational intervention, to an innovative smartphone app (mDASHNa-CC) to enable Chinese Canadian seniors' access to this antihypertensive dietary intervention anytime, regardless of where they are.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for early_phase_1 hypertension

Timeline
Completed

Started Jan 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 18, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

January 10, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

June 18, 2019

Status Verified

June 1, 2019

Enrollment Period

11 months

First QC Date

June 8, 2019

Last Update Submit

June 15, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • change of systolic Blood Pressure from baseline to eight weeks after randomization

    Systolic blood pressures will be measured by the home blood pressure monitor, Omron BP785, whose validity and reliability have been tested

    eight weeks after randomization

  • change of diastolic Blood Pressure from baseline to eight weeks after randomization

    diastolic blood pressures will be measured by the home blood pressure monitor, Omron BP785, whose validity and reliability have been tested

    eight weeks after randomization

  • change of body weight from baseline to eight weeks after randomization

    Weight will be measured by an electronic body weight scale (Rubbermaid® Digital Utility Scale, Model number H-479, Capacity/Accuracy 400 lbs \* 0.5 lb)

    eight weeks after randomization

  • change of waist circumference from baseline to eight weeks after randomization

    Waist circumference will be measured by measurement tape following proper technique

    eight weeks after randomization

  • change of Health-related Quality of Life from baseline to eight weeks after randomization

    Health-related quality of life will be measured by Medical Outcomes Study 36-Item Short Form version two. The SF-36v2 required ten minutes to complete and consisted of 36 items and eight domains, which could be grouped into physical and mental component summaries. All domains were scored on a scale ranging from 0 to 100, wherein 0 represented the worst overall health status and 100 the best health status.

    eight weeks after randomization

Study Arms (2)

Control: Usual Care

NO INTERVENTION

All participants will (a) receive a general hypertension health education booklet from the Heart and Stroke Foundation of Ontario;(b) be encouraged to see their family physicians or primary health care providers regarding their blood pressure status; those who do not have a primary health care provider will be referred to a walk-in clinic or a community health centre; and (c) have access to family physicians, tele-health, emergency care, hospital and other health care facilities in the Greater Toronto Area as required.

Intervention: mDASHNa-CC app use

ACTIVE COMPARATOR

In addition to usual care, those participants randomized to the intervention group will be offered use of the app.Then, they will load the app in their smartphones and be requested to review educational contents, conduct dietary self-assessment, and monitor blood pressure for 8 weeks.By the end of eight weeks post randomization, seniors will be prompted by phone using an audible alert to complete the app Evaluation Questionnaire on the smartphone, which ascertains likes and dislikes with the app.

Device: mDASHNa App

Interventions

The functions of the app will include: (a) antihypertensive dietary education; (b) dietary self-assessment; (c) automatic feedback according to dietary self-assessment; (d) blood pressure monitoring; and (e) automatic feedback according to blood pressure data.

Intervention: mDASHNa-CC app use

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • have a systolic blood pressure higher than 140 mmHg, or a diastolic blood pressure higher than 90mmHg, or are on antihypertensive medications, based on pre-intervention baseline assessment
  • are able to understand (listen) and speak in Mandarin or Cantonese, read and write in Chinese
  • have access to a smartphone

You may not qualify if:

  • have special dietary requirements
  • are a household member of another mDASHNa-CC participant
  • plan to leave the area prior to the anticipated end of study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Zou P, Stinson J, Parry M, Dennis CL, Yang Y, Lu Z. A Smartphone App (mDASHNa-CC) to Support Healthy Diet and Hypertension Control for Chinese Canadian Seniors: Protocol for Design, Usability and Feasibility Testing. JMIR Res Protoc. 2020 Apr 2;9(4):e15545. doi: 10.2196/15545.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A pilot two-group (1:1) randomized controlled trial with a sample size of 60 (block of 20) in a Chinese Canadian community in the Greater Toronto Area, Ontario, Canada.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 8, 2019

First Posted

June 18, 2019

Study Start

January 10, 2020

Primary Completion

December 1, 2020

Study Completion

June 30, 2021

Last Updated

June 18, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share